wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39257661-93494039-2E5F-430B-BE1F-9432CE68BAA2
Q39257661-93494039-2E5F-430B-BE1F-9432CE68BAA2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39257661-93494039-2E5F-430B-BE1F-9432CE68BAA2
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.
P2860
Q39257661-93494039-2E5F-430B-BE1F-9432CE68BAA2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39257661-93494039-2E5F-430B-BE1F-9432CE68BAA2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a99b9818c7e0951f561b751be2f5774161f238da
P2860
Phase III trials with docetaxel-based combinations for metastatic castration-resistant prostate cancer: time to learn from past experiences.